Literature DB >> 24838674

Oncoapoptotic markers in oral cancer: prognostics and therapeutic perspective.

Anubhav Jain1, Saurabh Bundela, Ram P Tiwari, Prakash S Bisen.   

Abstract

Oral cancer is one of the most commonly found cancers in many South-Asian underdeveloped countries, especially among men in comparison to women. When considering the mortality rate among all types of existing cancers, in India oral cancer is the primary reason for death in men. Some of the major reasons contributing to the high mortality rate are late diagnosis, lack of treatment options and high prevalence of tobacco consumption. Oral cancer is often diagnosed at a stage when cancer cells have already become aggressive and become resistant to standard therapeutic options. Progression, apoptosis, angiogenesis, metastasis and invasion behold great capability to treat and detect cancer at the molecular level. Dysregulation of apoptosis is one of the most common molecular events known to be associated with the development of oral cancer. In this review, we discuss key apoptotic markers which can be used as prognostic and/or therapeutic targets in oral cancer.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24838674     DOI: 10.1007/s40291-014-0104-5

Source DB:  PubMed          Journal:  Mol Diagn Ther        ISSN: 1177-1062            Impact factor:   4.074


  136 in total

1.  Co-expression of p53 and Ki67 and lack of EBV expression in oral squamous cell carcinoma.

Authors:  Anak Iamaroon; Udomrat Khemaleelakul; Surawut Pongsiriwet; Jarupan Pintong
Journal:  J Oral Pathol Med       Date:  2004-01       Impact factor: 4.253

2.  Up-regulation of Fas ligand and down-regulation of Fas expression in oral carcinogenesis.

Authors:  Q Chen; L P Samaranayake; X Zhen; G Luo; M Nie; B Li
Journal:  Oral Oncol       Date:  1999-11       Impact factor: 5.337

3.  Small molecule obatoclax (GX15-070) antagonizes MCL-1 and overcomes MCL-1-mediated resistance to apoptosis.

Authors:  Mai Nguyen; Richard C Marcellus; Anne Roulston; Mark Watson; Lucile Serfass; S R Murthy Madiraju; Daniel Goulet; Jean Viallet; Laurent Bélec; Xavier Billot; Stephane Acoca; Enrico Purisima; Adrian Wiegmans; Leonie Cluse; Ricky W Johnstone; Pierre Beauparlant; Gordon C Shore
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-26       Impact factor: 11.205

4.  Serum p53 antibodies as a prognostic indicator in oral squamous cell carcinoma.

Authors:  Yutaka Yamazaki; Itsuo Chiba; Makoto Ishikawa; Chiharu Satoh; Ken-Ichi Notani; Yoichi Ohiro; Yasunori Totsuka; Shigeaki Mizuno; Yoshimasa Kitagawa
Journal:  Odontology       Date:  2008-07-27       Impact factor: 2.634

5.  Antimycin A mimics a cell-death-inducing Bcl-2 homology domain 3.

Authors:  S P Tzung; K M Kim; G Basañez; C D Giedt; J Simon; J Zimmerberg; K Y Zhang; D M Hockenbery
Journal:  Nat Cell Biol       Date:  2001-02       Impact factor: 28.824

6.  Stabilization of p53 by CP-31398 inhibits ubiquitination without altering phosphorylation at serine 15 or 20 or MDM2 binding.

Authors:  Wenge Wang; Rishu Takimoto; Farzan Rastinejad; Wafik S El-Deiry
Journal:  Mol Cell Biol       Date:  2003-03       Impact factor: 4.272

7.  Expression of p16, p53 and Ki-67 proteins in the progression of epithelial dysplasia of the oral cavity.

Authors:  Francesca Angiero; Angiola Berenzi; Anna Benetti; Elisa Rossi; Rachele Del Sordo; Angelo Sidoni; Michele Stefani; Enrico Dessy
Journal:  Anticancer Res       Date:  2008 Sep-Oct       Impact factor: 2.480

8.  Direct activation of the apoptosis machinery as a mechanism to target cancer cells.

Authors:  Jack T Nguyen; James A Wells
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-13       Impact factor: 11.205

Review 9.  p73: Friend or foe in tumorigenesis.

Authors:  Gerry Melino; Vincenzo De Laurenzi; Karen H Vousden
Journal:  Nat Rev Cancer       Date:  2002-08       Impact factor: 60.716

10.  YM155, a novel small-molecule survivin suppressant, induces regression of established human hormone-refractory prostate tumor xenografts.

Authors:  Takahito Nakahara; Aya Kita; Kentaro Yamanaka; Masamichi Mori; Nobuaki Amino; Masahiro Takeuchi; Fumiko Tominaga; Shinji Hatakeyama; Isao Kinoyama; Akira Matsuhisa; Masafumi Kudoh; Masao Sasamata
Journal:  Cancer Res       Date:  2007-09-01       Impact factor: 13.312

View more
  4 in total

Review 1.  The Microenvironment of Tongue Cancer.

Authors:  Want Tao; Zeng Li-Juan; Li Kan; Li Jing-Yuan; Liu Xiang-Qi; Liang Yu-Jie
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

2.  Identification of autophagy-related biomarker and analysis of immune infiltrates in oral carcinoma.

Authors:  Honghai Fu; Dianguo Zhao; Legang Sun; Yumei Huang; Xiangrui Ma
Journal:  J Clin Lab Anal       Date:  2022-04-14       Impact factor: 3.124

Review 3.  Caspase 3 and Cleaved Caspase 3 Expression in Tumorogenesis and Its Correlations with Prognosis in Head and Neck Cancer: A Systematic Review and Meta-Analysis.

Authors:  Fábio França Vieira E Silva; María Elena Padín-Iruegas; Vito Carlo Alberto Caponio; Alejandro I Lorenzo-Pouso; Paula Saavedra-Nieves; Cintia Micaela Chamorro-Petronacci; José Suaréz-Peñaranda; Mario Pérez-Sayáns
Journal:  Int J Mol Sci       Date:  2022-10-08       Impact factor: 6.208

Review 4.  Major Molecular Signaling Pathways in Oral Cancer Associated With Therapeutic Resistance.

Authors:  Saima Usman; Ahmad Jamal; Muy-Teck Teh; Ahmad Waseem
Journal:  Front Oral Health       Date:  2021-01-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.